Trying to turn ‘natural killers’ against cancer, Peninsula drug maker raises $114 million For more information please click here to contact Tuan Nguyen By Bizjournals.com Feed (2019-07-12 16:19:27) | September 4, 2019 Paul Hastings’ South San Francisco biotech company is in line for an IPO. Posted in Sacramento Business Journal